ICCC
IMMUCELL CORP /DE/
NASDAQ · Healthcare · Biotechnology · US
$10.51
−2.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- 124.23x
- PEG TTM
- —
- Price / book
- 3.04x
- Price / sales
- 3.11x
- Price / cash flow
- 16.20x
Enterprise value
- Enterprise value
- $99.0M
- EV / sales
- 3.23x
- EV / EBITDA
- 28.01x
- EV / EBIT
- 25.62x
- Market cap
- $95.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026